Cleland et al., “Recombinant Human Growth Hormone Poly (Lactic-Co-Glycolic Acid) (PLGA) Microspheres Porvide a Long Lasting Effect,” J. Controlled Release 49:193-205 (1997). |
Hora et al., “Controlled Release of Interleukin-2 From Biodegradable Microspheres,” Bio/Technology 8:755-758 (1990). |
Johnson et al., “A Month-Long Effect from a Single Injection of Microencapsulated Human Growth Hormone,” Nature Medicine 2(7):795-799 (1996). |
Lam et al., “Sustained Release of Recombinant Human Insulin-like Growth Factor-I for Treatment of Diabetes,” American Assn. of Pharmaceutical Scientists, Western Regional Meeting, Apr. 24-25, 1997, South San Francisco. |
Tada et al., “Controlled Release System for IGF-I,” Proceed. Int'l. Symp. Control. Rel. Bioact. Mater. 24:889-890 (1997). |
Jeffrey, Haley, et al., “The Preparation and Characterization of Poly(lactide-co-glycolide) Microparticles. II. The Entrapment of a Model Protein Using a (water-in-Oil)-in-Water Emulsion Solvent Evaporation Technique,” Pharmaceutical Research 10:362-368 (1993). |
Hofrichter et al., “Kinetics and Mechanism of Deoxyhemoglobin S Gelation: A New Approach to Understanding Sickle Cell Disease,” Proc. Nat. Acad. Sci. USA 71(12):4864-4868 (1974). |
Johnson et al., “The Stabilization and Encapsulation of Human Growth Hormone Into Biodegradable Microspheres,” Pharmaceutical Research 14(6):730-735 (1997). |